SCHEMBL4166185

SCHEMBL4166185

CC(=O)c1cccc(NC(=O)[C@H](CCCSCC(=O)C(F)(F)F)NC(=O)Cc2ccsc2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
TDP1 Q9NUW8 1/20 0.42
ALDH1A1 P00352 6/20 0.42
TSHR P16473 2/20 0.42
CYP1A2 P05177 2/20 0.38
CYP2D6 P10635 2/20 0.38
CYP2C19 P33261 2/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
KMT2A Q03164 5/20 0.37
POLB P06746 3/20 0.37
MEN1 O00255 2/20 0.37
ALOX15 P16050 2/20 0.37
HTT P42858 2/20 0.37
HSD17B10 Q99714 2/20 0.37
ESR1 P03372 1/20 0.37
LMNA P02545 1/20 0.36
FNTA P49354 1/20 0.35
FNTB P49356 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4606348 0.85 POLB (0.39) NPC1RAB9ATDP1KMT2APOLB
SCHEMBL4174395 0.84 ALDH1A1 (0.48) NPC1RAB9AALDH1A1TSHRCYP1A2
Trifluoroacetic Acid SCHEMBL4169498 0.83 HDAC4 (0.39) ALDH1A1LMNAHDAC4MEF2D
SCHEMBL4164026 0.82 ALDH1A1 (0.54) NPC1RAB9AALDH1A1TSHRCYP1A2
SCHEMBL3507991 0.82 ALDH1A1 (0.45) NPC1RAB9AALDH1A1TSHRCYP1A2
SCHEMBL4174445 0.82 HDAC1 (0.42) NPC1RAB9AALDH1A1TSHRCYP1A2
SCHEMBL4160412 0.81 HTT (0.46) NPC1RAB9AALDH1A1TSHRCYP1A2
SCHEMBL4605724 0.79 CES1 (0.46)
SCHEMBL5122275 0.79 NPC1 (0.45) NPC1RAB9ATDP1ALDH1A1TSHR
SCHEMBL4158976 0.78 HDAC4 (0.53) ALDH1A1TSHRKMT2AMEN1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090054448-A1 Amino Acid Derivatives as Histone Deacetylase (HDAC) Inhibitors JONES PHILIP 2009-02-26 US disclosed
EP-1945609-A2 AMINO ACID DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI S.P.A. (IT) 2008-07-23 EP disclosed
WO-2007029036-A2 AMINO ACID DERIVATIVES AS HISTONE DEACETYLASE (HDAC) INHIBITORS ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI SPA (IT) 2007-03-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054448-A1 Amino Acid Derivatives as Histone Deacetylase (HDAC) Inhibitors HDAC5, HDAC1, HDAC11 NPC1 1625/4885RAB9A 1138/4885TDP1 1455/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.